LABT

Conviction 0HealthcareScan · Thu, Jun 25, 2026

Three inside down

LABT$3.39-8.87%

ResistanceSupportVol 14

Vol MA14 457.79K

Apr 23May 6May 18Jun 1Jun 11Jun 25

Lakewood-Amedex Biotherapeutics Inc.Biotechnologylakewoodamedex.com ↗

Price3.39

Change-8.87%

Gap-1.08%

Rel volume0.46×

Avg volume451.22K

Avg $ vol474.16K

SMA 201.27

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 2.20

RSI (14)61

MACD hist0.52

MACD cross—

Stoch %K / %D69 / 76

ADX (14)54

+DI / −DI44 / 17

RSI divergenceBullish

MACD divergence—

ATR %+18.22%

ADR %16.08%

52w high8.65

52w low0.3861

From 52w high-60.81%

Above 52w low+778.01%

New 52w highNo

SqueezeOff

Bollinger width381.25%

%B0.94

Donchian pos69.45%

Donchian high4.72

Donchian low0.3660

AVWAP (52w high)2.63

vs AVWAP high+28.67%

AVWAP (52w low)1.85

vs AVWAP low+83.54%

OBV trendDown

Chaikin MF (20)-0.23

Today vs 20d0.46×

Avg vol (14d)457.79K

Avg vol (20d)451.22K

Avg $ vol (20d)474.16K

Market cap23.71M

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank78.8

1 week+462.94%

1 month+376.12%

3 months—

6 months—

1 year—

YTD-60.81%

P/E—

P/B-8.35

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current0.02

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value23.7M

Revenue—

Net income-923.29K

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out14.32M

Employees—

ListedThu, Apr 23, 2026

Free float283.27K

Float %16.2%

Short interest39.02K

Days to cover0.0d

Short volume57.4%

Squeeze score39 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank78.8 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmThree inside down

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LABT

All disclosures →

No recent disclosed trades by Congress in LABT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LABT · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Tucker Joseph Edward Director · Warrant to acquire Common Stock · 2026-04-24	Grant	33.78K	$0	2026-04-24	2026-05-06

SEC filings

EDGAR filings in LABT · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.